Sugi Predict

Sugi Predict / Compounds / SCHEMBL19968353

SCHEMBL19968353

SCHEMBL19968353

Fc1ccc(P(I)c2ccc(F)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.39
▸ CA1 P00915 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ CA7 P43166 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ ORAI1 Q96D31 1/20 0.33
▸ ORAI2 Q96SN7 1/20 0.33
▸ ORAI3 Q9BRQ5 1/20 0.33
▸ TRPV6 Q9H1D0 1/20 0.33
▸ CES2 O00748 1/20 0.33
▸ CES1 P23141 1/20 0.33
▸ LOXL2 Q9Y4K0 1/20 0.33
▸ APP P05067 1/20 0.31
▸ TAAR1 Q96RJ0 1/20 0.31
▸ NFE2L2 Q16236 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL196718 0.73 CYP3A4 (0.44) IDO1CA1CA2CA7CA9
SCHEMBL7933208 0.71 CA1 (0.40) IDO1CA1CA2CA7CA9
SCHEMBL5713320 0.71 CYP3A4 (0.42) IDO1CA1CA2CA7CA9
SCHEMBL13499 0.71 — —
SCHEMBL19968564 0.69 ALDH1A1 (0.43) IDO1ORAI1ORAI2ORAI3TRPV6
SCHEMBL10340766 0.69 IDO1 (0.39) IDO1CA1CA2CA7CA9
Hydrochloric Acid SCHEMBL21724713 0.69 CYP3A4 (0.40) IDO1CA1CA2CA7CA9
SCHEMBL2539209 0.69 ACHE (0.45) IDO1CA1CA2CA7CA9
SCHEMBL2153517 0.69 CA1 (0.38) IDO1CA1CA2CA7CA9
SCHEMBL2886150 0.69 IDO1 (0.39) IDO1CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113896607-B Olefin oligomerization process using a catalyst comprising a chromium complex having a phosphacycle-containing ligand 陶氏环球技术有限责任公司 2024-04-16 — — CN disclosed
US-20220176363-A1 PROCESS FOR OLIGOMERIZATION DOW GLOBAL TECHNOLOGIES LLC (US) 2022-06-09 — — US disclosed
CN-107548385-B Olefin oligomerization process using catalyst comprising chromium complex with phosphacycle-containing ligand 陶氏环球技术有限责任公司 2022-01-21 — — CN disclosed
CN-113896607-A Olefin oligomerization process using catalyst comprising chromium complex with phosphacycle-containing ligand 陶氏环球技术有限责任公司 2022-01-07 — — CN disclosed
CN-107592863-B Chromium complexes with ligands containing phosphacycles and olefin oligomerization catalysts therefrom 陶氏环球技术有限责任公司 2021-09-10 — — CN disclosed
CN-107567355-B Phosphacycle-containing ligands for chromium complexes and olefin oligomerization catalysts therefrom 陶氏环球技术有限责任公司 2021-07-23 — — CN disclosed
US-20210129125-A1 PROCESS FOR OLIGOMERIZATION DOW GLOBAL TECHNOLOGIES LLC (US) 2021-05-06 — — US disclosed
US-10981156-B2 Chromium complex and catalyst therefrom DOW GLOBAL TECHNOLOGIES LLC (US) 2021-04-20 — — US disclosed
US-10919031-B2 Process for oligomerization DOW GLOBAL TECHNOLOGIES LLC (US) 2021-02-16 — — US disclosed
US-20200338542-A1 PROCESS FOR OLIGOMERIZATION DOW GLOBAL TECHNOLOGIES LLC (US) 2020-10-29 — — US disclosed
US-10702861-B2 Process for oligomerization DOW GLOBAL TECHNOLOGIES LLC (US) 2020-07-07 — — US disclosed
US-20200030783-A1 PROCESS FOR OLIGOMERIZATION DOW GLOBAL TECHNOLOGIES LLC (US) 2020-01-30 — — US disclosed
US-10376869-B2 Process for oligomerization DOW GLOBAL TECHNOLOGIES LLC (US) 2019-08-13 — — US disclosed
US-20190210013-A1 CHROMIUM COMPLEX AND CATALYST THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2019-07-11 — — US disclosed
US-10207262-B2 Chromium complex and catalyst therefrom DOW GLOBAL TECHNOLOGIES LLC (US) 2019-02-19 — — US disclosed
US-20180154344-A1 PROCESS FOR OLIGOMERIZATION DOW GLOBAL TECHNOLOGIES LLC (US) 2018-06-07 — — US disclosed
US-20180071725-A1 CHROMIUM COMPLEX AND CATALYST THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2018-03-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210129125-A1 PROCESS FOR OLIGOMERIZATION OXER1, NOD1, LIG1 IDO1 529/4885CA1 2491/4885CA2 2179/4885
US-20200338542-A1 PROCESS FOR OLIGOMERIZATION OXER1, NOD1, LIG1 IDO1 529/4885CA1 2491/4885CA2 2179/4885
US-20180071725-A1 CHROMIUM COMPLEX AND CATALYST THEREFROM OXER1, LIG1, PICALM IDO1 759/4885CA1 1187/4885CA2 853/4885
US-10919031-B2 Process for oligomerization OXER1, NOD1, LIG1 IDO1 529/4885CA1 2491/4885CA2 2179/4885
US-10376869-B2 Process for oligomerization OXER1, NOD1, LIG1 IDO1 529/4885CA1 2491/4885CA2 2179/4885
US-10981156-B2 Chromium complex and catalyst therefrom OXER1, LIG1, PICALM IDO1 759/4885CA1 1187/4885CA2 853/4885
US-10207262-B2 Chromium complex and catalyst therefrom OXER1, LIG1, PICALM IDO1 759/4885CA1 1187/4885CA2 853/4885
US-20200030783-A1 PROCESS FOR OLIGOMERIZATION OXER1, NOD1, LIG1 IDO1 529/4885CA1 2491/4885CA2 2179/4885
US-20180154344-A1 PROCESS FOR OLIGOMERIZATION OXER1, NOD1, LIG1 IDO1 529/4885CA1 2491/4885CA2 2179/4885
US-20220176363-A1 PROCESS FOR OLIGOMERIZATION OXER1, NOD1, LIG1 IDO1 529/4885CA1 2491/4885CA2 2179/4885
US-20190210013-A1 CHROMIUM COMPLEX AND CATALYST THEREFROM OXER1, LIG1, PICALM IDO1 759/4885CA1 1187/4885CA2 853/4885
US-10702861-B2 Process for oligomerization OXER1, NOD1, LIG1 IDO1 529/4885CA1 2491/4885CA2 2179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.